SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending due to speculation around its potential addition to the S&P 500, sparking debate about the company's financials and valuation; some traders believe inclusion is a sign of market corruption and a chance for insiders to offload shares, while others anticipate further gains. The community is actively discussing insider trading allegations, the sustainability of the company's business model amid rising auto loan delinquencies, and whether it represents a short opportunity or a long-term investment.

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

TREASURE GLOBAL INC

TREASURE GLOBAL INC ($TGL) is trending due to its recent 1-for-20 reverse split and subsequent Nasdaq compliance, sparking significant price volatility. The community is drawing comparisons to similar low-float runners like $SMX, with discussions focused on potential short squeezes and further upward momentum. Traders are closely monitoring price levels and catalysts for potential continuation into next week.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Inu ($SAILANA) is trending as its community, the Wolfpack, rallies around the memecoin's long-term vision and upcoming WolfSWAP release, emphasizing decentralization and utility. Discussions highlight the project's strong community, comparisons to early Shiba Inu, and the anticipation of a major release in 2026. The community is actively pushing against KOLs and championing a community-driven approach.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics ($CVKD) is trending due to positive community sentiment and bullish technical indicators, with some traders highlighting its potential for a breakout. The stock is a low-float healthcare microcap with upcoming catalysts, while community members discuss buyers building positions and momentum increasing. Overall, traders are optimistic about potential gains and are actively monitoring the stock's progress.

Wheeler Real Estate Investment Trust, Inc. engages in the acquisition, finance, development, lease, ownership, and management of retail properties. Its property portfolio includes income producing, strip centers, neighborhood, grocery-anchored, community, and free-standing retail properties. The company was founded on June 23, 2011 and is headquartered in Virginia Beach, VA.

Wheeler Real Estate Investment Trust Inc

WHLR is trending due to significant intraday volatility and a massive surge in trading volume, reminiscent of recent moves seen in other low-float stocks like $SMX. The community is actively discussing potential short squeezes, price targets, and the impact of recent Q3 results and perceived share dilution. Traders are closely watching for continuation, with some drawing parallels to $SMX's explosive run.

Ubiquiti, Inc. engages in the business of selling equipment and provision of related software platforms. It operates through the Enterprise Technology and Service Provider Technology product categories. The company was founded by Robert J. Pera in October 2003 and is headquartered in New York, NY.

Ubiquiti Inc

Ubiquiti's stock is buzzing as investors analyze its recent performance and future strategy, with community members closely watching direct vs. distributor sales and debt repayment progress. Some are speculating on potential buybacks and a possible short squeeze due to increased short positions, while others debate valuation concerns and inventory levels. Discussions also involve potential new product offerings and Ubiquiti's positioning in the enterprise market, in light of competitor activities.

Honda Motor Co., Ltd. engages in the manufacture and sale of automobiles, motorcycles, and power products. It operates through the following segments: Automobile, Motorcycle, Financial Services, and Power Product and Other Businesses. The Automobile segment manufactures and sells automobiles and related accessories. The Motorcycle segment handles all-terrain vehicles, motorcycle business, and related parts. The Financial Services segment provides financial and insurance services. The Power Product and Other Businesses segment offers power products and relevant parts. The company was founded by Soichiro Honda on September 24, 1948 and is headquartered in Tokyo, Japan.

Honda Motor - ADR

Honda Motor Co., Ltd.

Honda is trending as investors assess recent sales declines and a recall of 256,600 Accord Hybrids. Despite some negative sentiment, the community is also discussing Honda's hydrogen market potential and advanced air mobility initiatives. Discussions include potential partnerships, EV strategy shifts, and comparisons to competitors.

Hippo Holdings, Inc. is a home protection company which provides a new standard of care and protection for homeowners. It harnesses real-time data, smart home technology, and a growing suite of home services to create an integrated home protection platform. It operates through following segments: Services, Insurance-as-a-Service, and Hippo Home Insurance Program. The Services segment earns fees and/or commission income without assuming underwriting risk or need for reinsurance. The Insurance-as-a-Service segment earns a portion of the premiums paid to it for the risk the company retains as well as generates investment income. The Hippo Home Insurance Program segment involves the Hippo-branded homeowners insurance business. The company was founded by Assaf Wand on January 10, 2015 and is headquartered in San Jose, CA.

Hippo Holdings Inc

Hippo Holdings ($HIPO) is trending as investors assess its long-term potential following recent earnings and a challenging market environment. Community members are discussing the company's path to profitability, recent insider buying, and comparing it to peers in the Insurtech space like $LMND and $ROOT. Some view $HIPO as undervalued, while others remain skeptical, citing past performance and sector volatility.

Enerpac Tool Group Corp. engages in the provision of industrial tools, services, technology and solutions. It operates through the Industrial Tools and Services and Other segments. The Industrial Tools and Services segment supplies both products and services to a broad array of end markets, including the industrial, energy, mining, and production automation markets. The Other operating segment designs and manufactures synthetic ropes and biomedical assemblies. The company was founded in 1910 and is headquartered in Milwaukee, WI.

Enerpac Tool Group Corp - Ordinary Shares - Class A

$EPAC is trending amidst discussions about earnings expectations and recent reports, with community members actively weighing the stock's potential. Some are pointing to positive articles and strong institutional accumulation, while others express concerns about revenue and mixed performance metrics. A new share repurchase plan and updated ratings are also contributing to the conversation.

McGraw Hill, Inc. is a holding company, which engages in the provision of content and digital education solutions. It operates through the following segments: K-12, High Education, Global Professional, and International. The K-12 segment consists of blended digital and print learning solutions for end-to-end core, supplemental, and intervention curricula for K-12 schools. The High Education segment offers digital course experiences for nearly every subject through the flagship Connect solution. The Global Professional segment covers global content provision of medical and engineering learning solutions and support for learners and educational institutions. The International segment includes digital and print solutions for various countries and languages outside the United States. The company was founded in 1888 and is headquartered in Columbus, OH.

McGraw Hill Inc

McGraw Hill ($MH) is trending as analysts adjust their ratings following a strong earnings call. The community is buzzing about the company's transformation into an AI-driven educational powerhouse with a profitable business model. Some investors are also noting the broader healthcare sector's current strength and institutional interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MRK $GILD  
 
IMHO, even just a small slice in regards to licensing fees for $CDXS would have a HUGE impact on the company going forward.    
 
&quot;Pifeltro-islatravir will reach blockbuster status by 2030, with the combination estimated to pull in $1.7BN by 2033, as per a patient-based forecast from analysts at GlobalData. 
 
However, islatravir could have another shot at glory on the HIV market, as two Phase III trials are currently assessing islatravir plus Gilead’s HIV drug, Sunlenca (lenacapavir). The combination was recently found to maintain viral suppression for two years when administered orally once-weekly in a Phase II trial.&quot; 
 
https://www.clinicaltrialsarena.com/news/msd-merck-hiv-doravirine-islatravir-phase-iii/?cf-view

MSD's doravirine-islatravir did not meaningfully impact lipid metabolism or weight gain compared with SoC Biktarvy in HIV.

Clinical Trials Arena

MSD's HIV duo non-inferior to SoC in Phase III trials

$CDXS $MRK https://www.fiercebiotech.com/biotech/mercks-hiv-combo-matches-gileads-biktarvy-phase-3-test

Merck & Co. | Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval molecule as a new anchor treatment for the infectious disease.

Merck's HIV combo matches Gilead's Biktarvy in latest phase 3 test for islatravir

StockTwits Web

Codexis Inc.

Merck & Co Inc

Bobby McBean

Gilead Sciences, Inc.

  
 
IMHO, even just a small slice in regards to licensing fees for 

 would have a HUGE impact on the company going forward.    
 
"Pifeltro-islatravir will reach blockbuster status by 2030, with the combination estimated to pull in $1.7BN by 2033, as per a patient-based forecast from analysts at GlobalData. 
 
However, islatravir could have another shot at glory on the HIV market, as two Phase III trials are currently assessing islatravir plus Gilead’s HIV drug, Sunlenca (lenacapavir). The combination was recently found to maintain viral suppression for two years when administered orally once-weekly in a Phase II trial." 
 
